Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V
Diabetes Research Centre, M V Hospital for Diabetes, WHO Collaborating Centre for Research, Education and Training in Diabetes, 4 Main Road, Royapuram, Chennai 600 013 , India.
Diabetes Res Clin Pract. 2003 Jun;60(3):199-204. doi: 10.1016/s0168-8227(03)00060-3.
AIMS/HYPOTHESIS: To determine the prevalence of the Metabolic syndrome (MetS) using modified ATP III criteria in urban Asian Indian adults.
475 subjects (age 20-75 years) from a population data base were studied for the MetS using ATP III criteria but with a modified waist circumference (WC) appropriate for Indians. Presence of >or=3 of the following; raised WC (Men >or=90 cm, Women >or=85 cm), triglycerides (TG) >or=1.7 mmol/l), HDL-Cholesterol (HDL-C)-<1.0 mmol/l for men, <1.3 mmol/l for women, fasting plasma glucose (FPG)>or=6.1 mmol/l and blood pressure (BP)>or=130/>or=85 mm of Hg, or using BP medication, indicated the MetS. Insulin resistance (IR) was calculated using the Homeostasis Model Assessment (HOMA) equation. Factor analysis was used to identify clusters of correlated abnormalities.
MetS was present in 41.1%. WC was increased in 31.4%, TG in 45.6%, low HDL-C in 65.5%, hypertension in 55.4% and raised FPG 26.7%. MetS was present in 27.9% of subjects with FPG<6.1 mmol/l and its prevalence increased to >70% with higher FPG values. MetS was more common in women than in men (46.5 vs. 36.4%, chi(2)=4.6, P=0.03) and in older people. Four distinct clusters of abnormalities were identified with some gender variations. IR was more prevalent in MetS and was a component of two clusters but it was not a core component in factor analysis.
MetS is common in Asian Indians. Its prevalence is age-related, and is more common in women. HOMA-IR or fasting plasma insulin was not a core component of the MetS.
目的/假设:采用修改后的ATP III标准,确定亚洲印度城市成年人群中代谢综合征(MetS)的患病率。
对来自人群数据库的475名受试者(年龄20 - 75岁)进行研究,采用ATP III标准,但使用适合印度人的修改后的腰围(WC)。若存在以下≥3项情况:腰围增加(男性≥90厘米,女性≥85厘米)、甘油三酯(TG)≥1.7毫摩尔/升、高密度脂蛋白胆固醇(HDL - C)男性<1.0毫摩尔/升,女性<1.3毫摩尔/升、空腹血糖(FPG)≥6.1毫摩尔/升以及血压(BP)≥130/≥85毫米汞柱,或正在使用降压药物,则表明患有MetS。使用稳态模型评估(HOMA)方程计算胰岛素抵抗(IR)。采用因子分析来识别相关异常的聚类。
MetS的患病率为41.1%。腰围增加的比例为31.4%,甘油三酯升高的比例为45.6%,高密度脂蛋白胆固醇降低的比例为65.5%,高血压的比例为55.4%,空腹血糖升高的比例为26.7%。空腹血糖<6.1毫摩尔/升的受试者中,MetS的患病率为27.9%,随着空腹血糖值升高,其患病率增至>70%。MetS在女性中比男性更常见(46.5%对36.4%,χ² = 4.6,P = 0.03),且在老年人中更常见。识别出四个不同的异常聚类,存在一些性别差异。IR在MetS中更普遍,是两个聚类的组成部分,但在因子分析中它不是核心组成部分。
MetS在亚洲印度人群中很常见。其患病率与年龄相关,且在女性中更常见。HOMA - IR或空腹血浆胰岛素不是MetS的核心组成部分。